News
IDIBELL participates in Sónar+D to take a trip to the musical brain
A trip into the musical brain: this was the artistic and scientific experience that the 2020 edition of the Sónar+D Festival offered this past Saturday, within a special program that combined the streaming and face-to-face formats from the Center for Contemporary Culture of Barcelona. Dr. Antoni Rodríguez Fornells, a researcher at IDIBELL, ICREA and the […]
Jordi Guiu, the new group leader of the Regenerative Medicine Program
Jordi Guiu joins to IDIBELL as group leader and opens the Cell Plasticity and Regeneration group of the Regenerative Medicine Program
Stand-up science has started preparing IDIBELL scientists to become a science YouTubers
Six scientists from IDIBELL have received training to perform a scientific monologue in live and to produce an informative video on YouTube.
IDIBELL’s sarcoma research group will receive one of the new grants of AECC Innova
The group led by Dr. Óscar Martínez-Tirado will receive 180,000 euros in two years to develop a new therapy for Ewing’s sarcoma.
IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research
The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe. Awarded in the […]
The use of water pipes and passive exposure to their smoke are as harmful as conventional tobacco
Smoking in water pipes and passive exposure to the smoke they produce, increase the risk of lung cancer and other cardiovascular diseases. It is for this reason that its use should be regulated and compliance with the regulations guaranteed.
Artificial intelligence, a new tool against leukemia
Dr. Carolina M. Florian project has been selected by La Caixa Health Research grants
IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children
The chemoresistance group of IDIBELL and ICO’s ProCURE Program, led by Alberto Villanueva, has transferred its experience in generating orthotopic mouse models in adult patients to the pediatric field.